Advertisement

Topics

Q BioMed Begins Preparations to Test Drug Targeting a Patient Subset on the Autism Spectrum

04:00 EDT 10 Oct 2018 | Pharmaceutical Processing

The drug technology is being tested for pediatric developmental nonverbal disorder in toddlers within the autism spectrum disorders.
Staff Author: 

Original Article: Q BioMed Begins Preparations to Test Drug Targeting a Patient Subset on the Autism Spectrum

NEXT ARTICLE

More From BioPortfolio on "Q BioMed Begins Preparations to Test Drug Targeting a Patient Subset on the Autism Spectrum"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Autism
Autism affects half a million people in the UK. Men are affected more than women. People with autism have said that the world, to them, is a mass of people, places and events which they struggle to make sense of, and which can cause them considerable a...